secwatch.observer — SEC 8-K summary
======================================

Issuer:     NIKA PHARMACEUTICALS, INC (NIKA)
CIK:        0001145604
Form:       8-K
Filed at:   2024-10-01T23:59:59+00:00
Accession:  0001826466-24-000128
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01
LLM model:  deepseek-v4-flash:cloud@v2

Nika Pharmaceuticals hires OLAYINKA OYEBOLA & CO as new auditor
---------------------------------------------------------------

- Engaged OLAYINKA OYEBOLA & CO (Chartered Accountants) as independent auditor on September 23, 2024.
- Firm will audit the company's financial statements going forward.
- No mention of predecessor auditor or any accounting disagreements in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1145604/000182646624000128/0001826466-24-000128-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1145604/000182646624000128/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001826466-24-000128

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer